BioPerfectus

BioPerfectus is a publicly listed company on the Shanghai Stock Exchange, specializing in molecular diagnostics with a focus on infectious diseases and women's and children's health. Founded in 2010 and based in Jiangsu, China, the company operates multiple subsidiaries in major cities, including Shanghai and Beijing. The company is dedicated to research and development in advanced molecular diagnostic technologies, such as quantitative PCR, nucleic acid extraction solutions, and rapid testing methods. BioPerfectus offers a range of products, including real-time PCR kits, nucleic acid extraction systems, rapid diagnostic tests, and automated laboratory devices. Their commitment to innovation is supported by state-of-the-art PCR laboratories that follow strict safety protocols. BioPerfectus is recognized internationally and is a corporate member of the International Federation of Clinical Chemistry and Laboratory Medicine. The company actively participates in global health initiatives, supporting efforts against diseases like Ebola and COVID-19, and engages with the scientific community through international conferences and exhibitions.

• Employees 53
• Founded 2010